简单的可访问的克莱马斯烟酸相似物作为有效的antileishmanials
Rebecca L Charlton1,2, Douglas O Escrivani1,2, Christopher Brown1
1Department of Chemistry, Durham University Lower Mountjoy, South Rd Durham DH1 3LE UK p.g.steel@durham.ac.uk.
开发新的莱什曼病治疗方法至关重要. 克莱马斯丁烟酸的简单N结合类型显示出希望,提供更容易的合成和可比的有效性对抗Leishmania amazonensis.
科学领域:
- 药物的发现和开发.
- 寄生虫学的寄生虫学
- 药品化学 药品化学 是一个
背景情况:
- 莱什曼病是一个重大的全球健康挑战,治疗选择有限.
- 现有的莱什曼病治疗方法往往是有毒的和低于最佳的.
- 克莱马斯烟酸显示出抗莱什曼的活性,但很难合成.
研究的目的:
- 探索克莱马斯烟酸的N连接类型的合成和疗效.
- 确定潜在的新药候选药物,以改善莱什曼病治疗的特性.
- 在临床前模型中评估这些类似物的选择性和疗效.
主要方法:
- 合成克莱马斯丁烟酸的简单N结合类型.
- 在体外评估抗莱什曼尼尔活性和选择性.
- 在Leishmania amazonensis感染的小鼠模型中的 in vivo 疗效评估.
主要成果:
- 简单的N链类似物比克莱马斯烟酸更容易合成.
- 这些类似物显示出良好的抗莱什曼疗效.
- 与母化合物相比,类似物具有更好的选择性.
- 在Leishmania amazonensis感染的小鼠模型中观察到可比的疗效.
结论:
- 与N结合的类似物代表了开发改进的利什曼病治疗方法的有希望的途径.
- 更简单的合成和更强的选择性使这些类似物成为有吸引力的候选药物.
- 对这些类似物进行进一步的研究可能会导致更有效,更安全的莱什曼病治疗方法.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antipsychotic Drugs: Typical and Atypical Agents
Cholinergic Antagonists: Pharmacokinetics
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
